Matthew Call - 24 Jun 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Operating Officer
Signature
/s/ Michel Detheux, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 20:00:18 UTC
Next filing
05 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Award $0 +72,000 $0.000000 72,000 24 Jun 2021 Common Stock 72,000 $23.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest over 4 years, with 25% vesting on June 24, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.